Brain immune links between HIV, depression, and opioid use

Neuroimmune mechanisms involved in the complex co-morbidity Involving OUD, MDD, and HIV

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-11194515

This project looks at how immune-related changes in the brain connect HIV, major depression, and opioid use disorder using donated human brain tissue.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-11194515 on NIH RePORTER

What this research studies

If you or a loved one with HIV also had depression or problems with opioids and later choose to donate brain tissue, researchers will analyze that tissue to look for immune-related changes in a specific brain area called the subgenual anterior cingulate cortex (sgACC). They will use single-cell gene tests, ATAC-seq to study chromatin accessibility, and tissue staining to identify which cell types (especially microglia) are changed. By comparing people with different combinations of HIV, MDD, and OUD, the team aims to find shared cellular and molecular pathways that may explain overlapping symptoms like low mood and reduced motivation. Those findings could point toward new targets for treatments to help mood, motivation, and addiction in people living with HIV.

Who could benefit from this research

Good fit: People living with HIV who have a history of major depressive disorder and/or opioid use disorder, and who (or whose families) are willing to provide donated brain tissue and related clinical information, are ideal candidates for contributing to this work.

Not a fit: Because this work uses donated postmortem brain tissue to study mechanisms, people who do not have HIV, MDD, or OUD or who cannot participate in tissue donation are unlikely to receive direct personal benefit from this specific project.

Why it matters

Potential benefit: Could reveal immune-related brain targets that guide development of better treatments for depression and opioid problems in people living with HIV.

How similar studies have performed: Prior single-cell and postmortem brain studies have found disease-linked cell and molecular changes for HIV, depression, or opioid use separately, but analyzing all three conditions together in the same human brain region is a novel approach.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.